VKH
PTCT icon

Virtu KCG Holdings’s PTC Therapeutics PTCT Stock Holding History

Virtu KCG Holdings’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$455K Buy
+24,823
New +$334K 0.01% 1235
2017
Q1 		– Sell
-11,796
Closed -$129K – 3618
2016
Q4 		$129K Sell
11,796
-36,099
-75% -$379K ﹤0.01% 2811
2016
Q3 		$671K Buy
+47,895
New +$389K 0.02% 1087

Other funds holding PTCT

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Virtu KCG Holdings's PTCT Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in PTC Therapeutics (PTCT) in Q2 2017: 24,823 shares worth $455K. The stake represents 0.01% of the portfolio and ranks #1235 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in PTCT as recently as Q4 2016.

Virtu KCG Holdings first reported a position in PTCT in Q3 2016 and has held it in 3 quarters since. The position peaked at $671K in Q3 2016. 114 funds tracked by Wall St. Rank hold PTCT as of Q2 2017.

  • Virtu KCG Holdings held 24,823 shares of PTC Therapeutics worth $455K as of Q2 2017.
  • PTC Therapeutics was a new Virtu KCG Holdings position in Q2 2017.
  • PTC Therapeutics made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1235 holding.
  • Virtu KCG Holdings first reported a position in PTC Therapeutics in Q3 2016 and has held it in 3 quarters since.
  • Virtu KCG Holdings's PTC Therapeutics position peaked at $671K in Q3 2016.
  • 114 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.